Document Type

Article

Publication Date

March 2024

Patent Number

11939291

CPC

C07C 13/18 , C07D 213/62

Abstract

The present technology provides compounds according to Formula I or Formula III as well as compositions including such compounds useful for the treatment of metastatic cancer and/or glaucoma.

Application Number

17/226359

Assignees

University of Kansas

Filing Date

04/09/2021

Share

COinS